Celgene Market Access Executive in Madison, Wisconsin

Description

Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, ​quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.

The Market Access Executive is responsible for developing and managing the strategic planning and tactical efforts for assigned geography. The Market Access Executive works cross-functionally with Market Access partners, Sales franchises, Marketing and Celgene leadership to achieve / exceed goals.

*Preference is to have candidates living within the territory - Wisconsin, Illinois, Indiana, or Minnesota.

Responsibilities will include, but are not limited to, the following:

  • Develops the strategic objectives and tactical market access business plan for Celgene’s portfolio specific to assigned geography. Market segment responsibilities include, but are not limited to, Payers (Commercial, Medicare, and Medicaid), PBMs, State Medicaid & Medicare FFS, Regional SPs, Healthcare Coalitions, Employers, and Unions.

  • Effectively communicates with and leads cross-functional teams including Pricing & Contracting, Sales, Marketing, Medical, Health Economics, State Government Affairs, Policy, Patient Support and Senior Management to execute business plans and deliver results.

  • Secures, protects and/or improves access for the Celgene portfolio of products with any customer that implements a formulary or pathway, or accepts risk.

  • Sets direction to manage key decision makers and policymakers in assigned geography and promotion of Celgene products. Maximizes relationships with healthcare influencers to support product positioning.

  • Initiates pursuit of market access opportunities for all new product or new indication launches.

  • Aligns with Channel Marketing to assess and deploy approved resources in support of market access objectives.

  • Manages customer relationships that leads to level of trusted partner with C-Suite, Pharmacy Directors, Medical Directors, Formulary Directors, Clinical Pharmacists, Contract Managers, Claims Processors, Case Managers, Benefit Managers and other key influencers in assigned geography.

  • Works collaboratively with business partners (i.e. Market Access, Sales, Marketing, Pricing & Contracting, Corporate Affairs, Customer Care, Patient Support, Sales Ops, Regulatory, Legal, Finance, Market Research, Medical, etc.) to deliver a proactive and seamless approach to customers.

  • Understands complex market dynamics and influencers such as ACA, MACRA, Pathways, OCM, CMS and the relationships between upstream and downstream clients, i.e. IDNs, ACOs, PCMHs.

  • Effectively presents to internal (i.e. business plans, briefings, contract proposals) and external (i.e. FDAMA 114, value propositions, clinical decks) key stakeholders to increase awareness, garner support and achieve market access goals.

  • Designs, negotiates, executes and measures performance of rebate and value-based contracts across portfolio. Manages fiscal impact of pricing and contracting terms.

  • Effectively implements and executes pull through of National and Regional contracts.

  • Facilitates and provides timely marketplace feedback to Celgene management regarding business trends, issues, and/or opportunities.

Candidate Skills/Experiences:

  • 5+ years of large or complex key account management experience at Regional and/or National level

  • Payer, PBM, Employer, Specialty Pharmacy account management experience

  • Prior sales management and/or marketing experience

  • Experience in Hematology/Oncology and/or Immunology/Inflammatory therapeutic areas

  • Strong record of leadership and demonstration of leadership skills

  • Ability to take initiative and excel in an autonomous work environment

  • Existing relationships with key influencers/payers within the assigned geography

  • Knowledge of issues, trends and needs of Payers and Influencers within assigned geography

  • Experience in negotiating Payer/PBM Contracts

  • A comprehensive understanding of all Market Access customer segments

  • Successful experience with new product and expanded indication launches within Payer/PBM accounts

  • Demonstrated ability to work and integrate cross-functionally

  • Successfully able to create vision, present concept(s) and gain commitment from internal and external customers

  • The successful candidate must be proficient in the following competencies:

  • Business Acumen

  • Cross-Functional Partnership

  • Execution Excellence

  • Leadership

  • Results Driven

  • Customer Relationship Management

​*LI-POST

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.